New sound processor aims to boost hearing in noise

NCT ID NCT07156461

Completed Symptom relief Sponsor: Cochlear Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a new sound processor (Osia 3) helps adults with hearing loss or single-sided deafness hear better than the current model (Osia 2). Twenty-nine adults who already have a bone-anchored implant tried both processors. Researchers measured speech understanding in quiet and noisy settings, and asked participants about sound quality.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Osia 3 sound processor (device)
What this could lead to: If it works, this could mean better hearing in noise for people with certain types of hearing loss or single-sided deafness.
What could go wrong: This is a small, completed study with only 29 participants, so results may not apply to everyone. The improvement over the older device may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE CONDUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

conductive hearing loss disorder deafness, unilateral Hearing Loss, Conductive hearing loss, mixed conductive-sensorineural

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE CONDUCTION HEARING LOSS, CONDUCTIVE HEARING LOSS, MIXED SINGLE SIDED DEAFNESS

Contacts and locations

Locations

Cochlear Americas, Denver Research and Technology Lab

Denver, Colorado, 80124, United States
Cochlear Macquarie, Macquarie University

Sydney, New South Wales, 2109, Australia
HEARnet Clinical Studies

Melbourne, Victoria, 3010, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.